Pharmaceutical, Device & Diagnostic Companies
We have worked with a broad range of biopharmaceutical companies — from small biotechs to 18 of the top 20 large pharmas, as well as several diagnostic and device companies. We design and direct value-based deals, inform market access and development strategy, optimize patient support programs and enhance the effectiveness of market access teams and communications.
Payers & IDNs
We orchestrate value-based deals between payers/Integrated Delivery Networks (IDNs) and manufacturers. We also collaborate closely with a range of key payers and hospital systems as part of our Real Endpoints Payer Council (REPC).
Patient Advocacy Groups
We design programs to guide patients and caregivers in their journeys, facilitate financial support, and streamline drug access. We promote patient-centric drug development and help patients navigate treatment options based on their relative priorities.